Table 4.
The Top 20 Cited Papers in novel coronavirus (COVID-19) research
| Ranking | Authors | Title | Year | Source title | Cited by |
|---|---|---|---|---|---|
| 1st | Huang et al. [7] | “Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China” | 2020 | The Lancet | 2554 |
| 2nd | Wang et al. [9] | “Clinical Characteristics of 138 Hospitalized Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China” | 2020 | Journal of the American Medical Association | 1507 |
| 3rd | Guan et al. [46] | “Clinical characteristics of coronavirus disease 2019 in China” | 2020 | New England Journal of Medicine | 1469 |
| 4th | Zhu et al. [47] | “A novel coronavirus from patients with pneumonia in China, 2019″ | 2020 | New England Journal of Medicine | 1393 |
| 5th | Chen et al. [48] | “Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study” | 2020 | The Lancet | 1322 |
| 6th | Li et al. [49] | “Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia” | 2020 | New England Journal of Medicine | 1061 |
| 7th | Zhou et al. [3] | “Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study” | 2020 | The Lancet | 980 |
| 8th | Wu and McGoogan [50] | “Characteristics of and Important Lessons from the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72,314 Cases from the Chinese Center for Disease Control and Prevention” | 2020 | Journal of the American Medical Association | 964 |
| 9th | Zhou et al. [51] | “A pneumonia outbreak associated with a new coronavirus of probable bat origin” | 2020 | Nature | 931 |
| 10th | Chan et al. [52] | “A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster” | 2020 | The Lancet | 805 |
| 11th | Lu et al. [53] | “Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding” | 2020 | The Lancet | 724 |
| 12th | Holshue et al. [54] | “First case of 2019 novel coronavirus in the United States” | 2020 | New England Journal of Medicine | 585 |
| 13th | Yang et al. [55] | “Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study” | 2020 | The Lancet Respiratory Medicine | 521 |
| 14th | Wang et al. [56] | “Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro” | 2020 | Cell Research | 507 |
| 15th | Xu et al. [57] | “Pathological findings of COVID-19 associated with acute respiratory distress syndrome” | 2020 | The Lancet Respiratory Medicine | 485 |
| 16th | Van Doremalen et al. [58] | “Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1″ | 2020 | New England Journal of Medicine | 470 |
| 17th | Hoffmann et al. [59] | “SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor” | 2020 | Cell | 463 |
| 18th | Rothe et al. [60] | “Transmission of 2019-NCOV infection from an asymptomatic contact in Germany” | 2020 | New England Journal of Medicine | 403 |
| 19th | Mehta et al. [61] | “COVID-19: consider cytokine storm syndromes and immunosuppression” | 2020 | The Lancet | 389 |
| 20th | Zou et al. [62] | “SARS-CoV-2 viral load in upper respiratory specimens of infected patients” | 2020 | New England Journal of Medicine | 387 |